Our latest research findings
2022
- Associations between blood testosterone and DHEA and risk of ischaemic cardiovascular events in healthy older women; a prospective cohort sub-study of the ASPREE trial
- Q-122 as a novel, non-hormonal, oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blind, placebo-controlled trial
2021
- Longitudinal changes over three years in sex steroid hormone levels in women aged 70 years and over
- A prospective controlled study of sexual function and sexually related personal distress up to 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomy
- Differing performance of two assays for the measurement of anti-Mullerian hormone in premenopausal women, a cross-sectional study
- Use of community-based reference ranges to estimate the prevalence of polycystic ovary syndrome by the recognised diagnostic criteria, a cross-sectional study
- Health care providers' views of menopause and its management
- Testosterone and androstenedione are positively associated with anti-Müllerian hormone in premenopausal women
- Substituting serum AMH for polycystic ovarian morphology increases the number of women diagnosed with polycystic ovarian syndrome; a community-based cross-sectional study
- Functional hypothalamic amenorrhoea, a diagnosis of exclusion
2019
- Challenges in recruitment to an epidemiological study of young Australian Women: The Grollo-Ruzzene Foundation Young Women’s Health Study
- Traditional Sex Steroids and Ketoandrogen Levels by Menstrual Cycle Stage, Age and Body Mass Index in Women Aged 18-39 Years
- Iron insufficiency among young Australian women: a population‐based survey
- Testosterone: the known knowns, the known unknowns and the unknown unknowns
- Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data
- Hormonal contraceptive use in Australian women: Who is using what?
- Depressive symptoms and associated factors among Iranian women at midlife: a community-based, cross-sectional study
- Androgens during the reproductive years, what's normal for women?
- Testosterone and Estrone Increase From the Age of 70 Years: Findings From the Sex Hormones in Older Women Study
2018
- Menopause, lung function and obstructive lung disease outcomes: a systematic review
- Depressive symptoms and their risk factors in midlife women in the Middle East: a systematic review
- Identification of the gender-specific health needs of women following lung transplantation
- A systematic review of intravaginal testosterone for the treatment of vulvovaginal atrophy
- Moderate to severe vasomotor and sexual symptoms remain problematic for women aged 60 to 65 years
- Intravaginal Testosterone Improves Sexual Satisfaction and Vaginal Symptoms Associated With Aromatase Inhibitors
- Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis
- The benefits of adding metformin to tamoxifen to protect the endometrium – A randomized placebo-controlled trial
2017
- Prevalence and predictors of low sexual desire, sexually related personal distress, and hypoactive sexual desire dysfunction in a community-based sample of midlife women
- Moderate-severe vasomotor symptoms are associated with moderate-severe depressive symptoms
- Vasomotor symptoms are associated with depressive symptoms in community-dwelling older women
- Vasomotor symptoms in women in Asia appear comparable with women in Western countries: a systematic review
- Hypoactive sexual desire dysfunction in community-dwelling older women
- Aromatase inhibitors are associated with low sexual desire causing distress and fecal incontinence in women: An observational study
2016
- Effect of Adjunctive Raloxifene Therapy on Severity of Refractory Schizophrenia in Women: A Randomized Clinical Trial
- Hypoactive sexual desire dysfunction in community-dwelling older women
- Symptomatic pelvic floor disorders in community-dwelling older Australian women
- Androgens and Female Sexual Function and Dysfunction-Findings from the Fourth International Consultation of Sexual Medicine
- Menopausal vasomotor symptoms are assicated with poor self-assessed work ability
- Awareness of breast cancer barriers to breast screening uptake in Bangladesh: A population based survey
- Prevalence and severity of vasomotor symptoms and joint pain in women at midlife in Bangladesh: a population-based survey
- Hormones and female sexual dysfunction: Beyong estrogens and androgrens-Findings from the Fourth International Consultation on Sexual Medicine
- Treatment of symptoms of the menopause: An Endocrine Society Clinical Practice Guideline
- Prevalence of, and risk factors for, symptomatic pelvic organ prolapse in Rural Bangladesh: a cross-sectional survey study
2015
- Metformin for overweight women at midlife: a double-blind, randomized, controlled trial
- Moderate-severely bothersome vasomotor symptoms are associated with lowered psychological general wellbeing in women at midlife
- Moderate to severe vasomotor and sexual symptoms remain problematic for women aged 60 to 65 years
- Use of complementary and alternative medicines for menopausal symptoms in Australian women aged 40–65 years
- Bangladesh Midlife Women’s Health Study (BMWHS): Methods, challenges and experiences
- Lack of Understanding of Cervical Cancer and Screening Is the Leading Barrier to Screening Uptake in Women at Midlife in Bangladesh: Population-Based Cross-Sectional Survey
- Vasomotor and sexual symptoms in older Australian women: a cross-sectional study
- Targeted assessment of fracture risk in women at midlife